Age-related change in flicker thresholds with rod- and cone-enhanced stimuli.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 27 01 2020
accepted: 21 04 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 9 9 2020
Statut: epublish

Résumé

Rod and cone photoreceptor-specific tests can be time-consuming. A new non-invasive test is described. The test is based on the measurement of flicker modulation thresholds with rod- and cone-enhanced visual stimuli, which requires only minimum adaptation time. Here, we investigated how the rod-and cone-mediated flicker thresholds vary with age. Monocular thresholds with rod and cone-enhanced stimuli were measured in 140 healthy adults, (age range: 18-75 years), foveally (0°) and at four parafoveal locations, at an eccentricity of 5° in each of the four quadrants using five, adaptive, interleaved staircases. Temporal frequencies, stimulus sizes, background luminance and spectral composition, were adjusted appropriately to achieve approximately 1 log unit separation in sensitivity between the rod- and cone-enhanced stimuli. Spectrally calibrated, 'neutral density' filters were used to enable adequate control of display luminance for rod enhanced stimuli. The magnitude of central and parafoveal rod thresholds was significantly higher than the central and parafoveal cone thresholds, respectively (p < 0.001) in both the age groups. However, the rate of increase in central rod thresholds (y = 0.45x-12.79; linear regression equation) was not significantly steeper than the rate of increase in central (y = 0.29x-8.53) cone thresholds (p = 0.15). Centrally, cone thresholds showed a better correlation with rod central thresholds for the age > 45 years (Spearman correlation, ρ = 0.74, p < 0.001) compared to age ≤ 45 years (ρ = 0.41, p < 0.001). Thresholds with rod- and cone-enhanced stimuli are largely invariant below 45 years of age and increase rapidly above this age. This age-wise normative database can be used as an effective functional-marker to assess photoreceptor sensitivities in retinal diseases.

Identifiants

pubmed: 32639956
doi: 10.1371/journal.pone.0232784
pii: PONE-D-20-02487
pmc: PMC7343165
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0232784

Déclaration de conflit d'intérêts

AH and SRB received support in the form of salaries from the Hyderabad Eye Research Foundation. AS, JB, and JRES received support in the form of salaries from City University of London. JRES received support in the form of a salary from QinetiQ. The authors would like to declare the following patents/patent applications associated with this research: EU- EP08762401.1; US- US8,322,857: 'Vision testing apparatus and method.' This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

PLoS One. 2018 Jan 16;13(1):e0191141
pubmed: 29338027
Vision Res. 2004 Apr;44(8):833-8
pubmed: 14967208
Invest Ophthalmol Vis Sci. 2014 Mar 10;55(3):1427-31
pubmed: 24550363
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1132-7
pubmed: 8125724
Vision Res. 2001 Sep;41(19):2449-55
pubmed: 11483176
Ophthalmology. 2001 Jul;108(7):1196-202
pubmed: 11425675
Invest Ophthalmol Vis Sci. 1993 Oct;34(11):3096-102
pubmed: 8407217
Invest Ophthalmol Vis Sci. 2011 Dec 09;52(13):9457-69
pubmed: 22003115
Diabetes Care. 1987 Nov-Dec;10(6):777-81
pubmed: 3501362
Optom Vis Sci. 1998 Dec;75(12):867-72
pubmed: 9875991
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5666-5672
pubmed: 29098297
J Ocul Biol Dis Infor. 2008 Mar;1(1):7-11
pubmed: 20072631
Transl Vis Sci Technol. 2018 Mar 02;7(2):1
pubmed: 29520333
Vision Res. 1990;30(4):541-7
pubmed: 2339508
Arch Ophthalmol. 1993 Jun;111(6):831-6
pubmed: 8512486
J Acoust Soc Am. 1971 Feb;49(2):Suppl 2:467+
pubmed: 5541744
Vision Res. 1998 Jun;38(11):1723-9
pubmed: 9747505
Neurosci Lett. 1991 Jul 22;128(2):291-6
pubmed: 1945050
Vision Res. 2000;40(18):2467-73
pubmed: 10915886
Exp Brain Res. 2011 Dec;215(3-4):293-305
pubmed: 22006271
Ophthalmology. 2007 Sep;114(9):1728-35
pubmed: 17822978
Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7376-84
pubmed: 21724911
Curr Eye Res. 1986 Oct;5(10):717-24
pubmed: 3769522
Invest Ophthalmol Vis Sci. 1981 Feb;20(2):204-12
pubmed: 7461923
Optom Vis Sci. 2014 Aug;91(8):916-24
pubmed: 24978867
J Opt Soc Am A Opt Image Sci Vis. 2005 Jan;22(1):17-28
pubmed: 15669611
Arch Ophthalmol. 2004 Apr;122(4):598-614
pubmed: 15078679
Sci Rep. 2015 Dec 17;5:18291
pubmed: 26672758
Invest Ophthalmol Vis Sci. 1981 Mar;20(3):392-9
pubmed: 7203883
Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1240-6
pubmed: 7775101
Front Aging Neurosci. 2014 Jul 09;6:163
pubmed: 25071569
Vision Res. 1992 Jul;32(7):1199-209
pubmed: 1455694
Curr Diab Rep. 2015 Dec;15(12):118
pubmed: 26493191
Can J Ophthalmol. 1997 Aug;32(5):324-8
pubmed: 9276120
Surv Ophthalmol. 2014 Nov-Dec;59(6):627-35
pubmed: 25113611
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2824-30
pubmed: 17525218
Br J Ophthalmol. 2005 Jun;89(6):764-9
pubmed: 15923516
Invest Ophthalmol Vis Sci. 2011 May 02;52(6):2861-7
pubmed: 21282578
Eye (Lond). 2016 Feb;30(2):189-92
pubmed: 26656085
Transl Vis Sci Technol. 2016 Aug 31;5(4):13
pubmed: 27617180
Invest Ophthalmol Vis Sci. 1994 May;35(6):2741-8
pubmed: 8188467
J Comp Neurol. 1990 Feb 22;292(4):497-523
pubmed: 2324310
Invest Ophthalmol Vis Sci. 1989 Aug;30(8):1738-42
pubmed: 2759789
Invest Ophthalmol Vis Sci. 2014 May 22;55(8):4776-89
pubmed: 24854857
Invest Ophthalmol Vis Sci. 1991 Aug;32(9):2552-60
pubmed: 1869410
Vision Res. 1998 Nov;38(22):3655-62
pubmed: 9893796
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1236-49
pubmed: 8641827
Invest Ophthalmol Vis Sci. 2000 Jan;41(1):267-73
pubmed: 10634630
J Opt Soc Am A. 1989 Apr;6(4):481-90
pubmed: 2709193
Biomed Res Int. 2014;2014:768026
pubmed: 24707498
Invest Ophthalmol Vis Sci. 1992 Jan;33(1):1-17
pubmed: 1730530
Neuroscience. 2008 Oct 15;156(3):748-57
pubmed: 18775477
J Physiol. 1958 Apr 30;141(2):337-50
pubmed: 13539843
Eur J Neurosci. 2008 Jul;28(1):201-7
pubmed: 18616566
Can J Exp Psychol. 2002 Sep;56(3):177-86
pubmed: 12271748
Vision Res. 2011 Jul 1;51(13):1610-22
pubmed: 20974168
Vision Res. 1997 Feb;37(4):475-81
pubmed: 9156178
Ann Neurol. 1993 Mar;33(3):248-57
pubmed: 8498808
J Gen Physiol. 1936 Jul 20;19(6):965-77
pubmed: 19872976
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):55-65
pubmed: 18172075
Vision Res. 1999 Nov;39(23):3975-82
pubmed: 10748929
Exp Eye Res. 2013 Mar;108:1-9
pubmed: 23276813
J Comp Neurol. 1990 Oct 1;300(1):5-25
pubmed: 2229487
J Opt Soc Am A. 1988 Dec;5(12):2201-9
pubmed: 3230490
Ophthalmology. 2016 Feb;123(2):344-351
pubmed: 26522707
Anat Rec. 2000 Oct 1;260(2):124-31
pubmed: 10993949
Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3278-96
pubmed: 8225863
J Biomed Opt. 2011 Aug;16(8):085004
pubmed: 21895312
J Physiol. 1986 Feb;371:365-85
pubmed: 3486271
Doc Ophthalmol. 1985 Jun 30;59(4):385-95
pubmed: 4028926
Optom Vis Sci. 2008 May;85(5):309-17
pubmed: 18451735
Ophthalmic Surg Lasers Imaging Retina. 2017 Jan 1;48(1):45-50
pubmed: 28060393
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):387-95
pubmed: 26842756
J Opt Soc Am A Opt Image Sci Vis. 1994 Jul;11(7):1958-69
pubmed: 8071737
Optom Vis Sci. 1991 Oct;68(10):786-9
pubmed: 1749597

Auteurs

Amithavikram R Hathibelagal (AR)

Brien Holden Institute of Optometry and Vision Science, L V Prasad Eye Institute, Hyderabad, India.
Brien Holden Eye Research Centre, L V Prasad Eye Institute, Hyderabad, India.

Shrikant R Bharadwaj (SR)

Brien Holden Institute of Optometry and Vision Science, L V Prasad Eye Institute, Hyderabad, India.
Brien Holden Eye Research Centre, L V Prasad Eye Institute, Hyderabad, India.

Anil R Yadav (AR)

Brien Holden Institute of Optometry and Vision Science, L V Prasad Eye Institute, Hyderabad, India.
Brien Holden Eye Research Centre, L V Prasad Eye Institute, Hyderabad, India.

Ahalya Subramanian (A)

Centre for Applied Vision Research, School of Health Sciences, City, University of London, London, England, United Kingdom.

James R E Sadler (JRE)

Centre for Applied Vision Research, School of Health Sciences, City, University of London, London, England, United Kingdom.
Human Performance, QinetiQ, Hampshire, England, United Kingdom.

John L Barbur (JL)

Centre for Applied Vision Research, School of Health Sciences, City, University of London, London, England, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH